DW
Therapeutic Areas
Sun Pharmaceutical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Generic Semaglutide Injection | Chronic Weight Management | ANDA Approved |
| UNLOXCYT™ (cosibelimab-ipdl) | Advanced Cutaneous Squamous Cell Carcinoma (aCSCC) | Commercial |
| ILUMYA® (tildrakizumab-asmn) | Moderate-to-Severe Plaque Psoriasis | Commercial |
| Caritec (Assumed Brand) | Not Specified (Cardiometabolic) | Not Disclosed |